Cite
HARVARD Citation
Jacob, S. et al. (2020). Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study. Therapeutic advances in neurological disorders. p. . [Online].